beta
Trial Radar IA
Lo studio clinico NCT07364227 per Adhesive Capsulitis of the Shoulder, Intra Articular Injection è non ancora in arruolamento. Consulti la vista a schede del Radar degli Studi Clinici e gli strumenti di scoperta IA per tutti i dettagli. Oppure, ponga pure una domanda qui.
Un studio corrisponde ai criteri del filtro
Vista a schede
Torna alla ricerca

Anterior vs Posterior vs Combined Intra-Articular Injections for Adhesive Capsulitis 30 Randomizzato

Non ancora in arruolamento
I dettagli dello studio clinico sono disponibili principalmente in inglese. Tuttavia, Trial Radar IA può essere d'aiuto! Basta cliccare su 'Spiega lo studio' per visualizzare e discutere le informazioni sullo studio nella lingua selezionata.
La sperimentazione clinica NCT07364227 è uno studio interventistico per Adhesive Capsulitis of the Shoulder, Intra Articular Injection, attualmente non ancora in arruolamento. L'arruolamento dovrebbe iniziare il 1 gennaio 2026, con l'obiettivo di raggiungere 30 partecipanti. Sotto la guida di Aslinur Keles Ercisli, MD, PhD, dovrebbe concludersi entro il 1 luglio 2026. I dati più recenti da ClinicalTrials.gov sono stati aggiornati l'ultima volta il 23 gennaio 2026.
Sommario breve
This randomized controlled clinical trial aims to compare the efficacy of three different intra-articular injection approaches (anterior, posterior, and combined anterior-posterior) in patients with adhesive capsulitis of the shoulder. Thirty participants will be randomly assigned to one of three groups and treated with a standardized injection solution consisting of corticosteroid, lidocaine, and saline. Clinical ou...Mostra di più
Descrizione dettagliata
Adhesive capsulitis (frozen shoulder) is a disabling condition characterized by progressive pain and stiffness of the glenohumeral joint. Intra-articular corticosteroid injections are frequently used to reduce pain and improve mobility; however, the optimal injection approach remains controversial.

This single-center randomized controlled trial will investigate three different approaches: posterior, anterior, and co...

Mostra di più
Titolo ufficiale

Comparison of Anterior, Posterior, and Combined Intra-Articular Injection Techniques in Patients With Adhesive Capsulitis

Patologie
Adhesive Capsulitis of the ShoulderIntra Articular Injection
Altri ID dello studio
  • ADC2025
Numero NCT
NCT07364227
Data di inizio (effettiva)
2026-01
Ultimo aggiornamento pubblicato
2026-01-23
Data di completamento (stimata)
2026-07
Arruolamento (previsto)
30
Tipo di studio
Interventistico
FASE
N.D.
Stato
Non ancora in arruolamento
Parole chiave
Adhesive Capsulitis of the Shoulder
Intra-articular Injection
Frozen Shoulder
Ultrasound
Shoulder Pain
Scopo principale
Trattamento
Allocazione
Randomizzato
Modello di intervento
In parallelo
Mascheramento
Nessuno (studio in aperto)
Bracci / Interventi
Gruppo/Braccio di partecipantiIntervento/Trattamento
SperimentaleArm A: Posterior Injection
Single intra-articular injection with corticosteroid + lidocaine + saline via the posterior glenohumeral approach.
Intervention Name: Posterior Intra-articular Injection
A single intra-articular injection consisting of 1 cc corticosteroid, 4 cc 2% lidocaine, and 5 cc saline (total 10 cc) administered via the posterior glenohumeral approach.
SperimentaleArm B - Anterior Injection
Same injection solution administered via the anterior (rotator interval) approach.
Anterior Intra-articular Injection
A single intra-articular injection consisting of 1 cc corticosteroid, 4 cc 2% lidocaine, and 5 cc saline (total 10 cc) administered via the anterior (rotator interval) approach.
SperimentaleArm C - Combined Anterior + Posterior Injection
Same injection solution administered using both anterior and posterior approaches.
Combined Anterior + Posterior Intra-articular Injection
A single intra-articular injection consisting of 1 cc corticosteroid, 4 cc 2% lidocaine, and 5 cc saline (total 10 cc) administered using both anterior and posterior approaches during the same procedure.
Esito primario
Misure di esitoDescrizione della misuraArco temporale
Change in Shoulder Range of Motion (ROM)
Change in active and passive shoulder joint range of motion (flexion, extension, abduction, external rotation, internal rotation) measured with a goniometer.
Baseline, immediately post-injection, week 3, week 6, week 12
Esito secondario
Misure di esitoDescrizione della misuraArco temporale
Change in Pain Intensity (NRS)
Number Rating Scale (0-10) for pain at rest, during activity, and at night.
Baseline, immediately post-injection, week 3, week 6, week 12
Subjective Shoulder Value (SSV)
Patient's self-reported percentage of normal shoulder function (0-100%).
Baseline, immediately post-injection, week 3, week 6, week 12
Shoulder Pain and Disability Index (SPADI)
Questionnaire assessing pain and disability (0-100 score, higher scores = worse function).
Baseline, week 3, week 6, week 12
Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH)
Questionnaire measuring upper limb disability and symptoms (0-100 score, higher = worse).
Baseline, week 3, week 6, week 12
American Shoulder and Elbow Surgeons (ASES) Score
Composite score including pain and function (0-100, higher = better).
Baseline, week 3, week 6, week 12
Constant-Murley Shoulder Score
Clinical score combining pain, activities of daily living, strength, and ROM (0-100).
Baseline, week 3, week 6, week 12
Scratch Test Score
Functional test measuring the patient's ability to reach behind the back.
Baseline, immediately post-injection, week 3, week 6, week 12
Axillary Capsule Thickness (Ultrasound)
Ultrasound measurement of axillary recess capsule thickness on the affected shoulder.
Baseline, immediately post-injection (only).
Assistente alla partecipazione
Criteri di eleggibilità

Età idonea
Adulto, Adulto anziano
Età minima
18 Years
Sessi idonei
Tutti
Aslinur Keles Ercisli, MD, PhD logoAslinur Keles Ercisli, MD, PhD
Parte responsabile dello studio
Aslinur Keles Ercisli, MD, PhD, Promotore-investigatore, Principal investigator, Fatih Sultan Mehmet Training and Research Hospital
Contatti principali dello studio
Contatto: Aslinur K Keles, MD., PhD, +905395010707, [email protected]
Contatto: esra K giray, Assoc Prof, +90 555 813 43 94, [email protected]
Nessun dato sulle località